−0.5759USD
−21.27 MUSD
27.35 M
About Coeptis Therapeutics Holdings, Inc.
Sector
Industry
CEO
David Mehalick
Website
Headquarters
Wexford
Employees (FY)
7
Founded
2017
FIGI
BBG00XV39M53
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
